Home > Insider Trading > Filing (0000921895-23-001569)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
910267	Titan Pharmaceuticals Inc	TTNP	Biological Products, (No Disgnostic Substances) (2836)	943171940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1817604	Activist Investing Llc	1185 Avenue Of The Americas, 3Rd Floor. New York NY 10036		No	No	No	Yes
1932843	E. David Lazar	Villa 1, 14-43Rd Street Jumeirah 2 Dubai C0 00000	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Disposition	2023-06-21	3,388,902	$1.23	0	No	4	S	Direct
Common Stock, Par Value $0.001	Disposition	2023-06-21	359,066	$1.23	0	No	4	S	Indirect	By Activist Investing LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	By Activist Investing LLC

Footnotes

These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.